Dorzagliatin promising novel hypoglycemic drug for type 2 diabetes: Study Written By Medha Baranwal3 March 2024 6:30 PM ISTChina: A randomized controlled trials (RCTs) meta-analysis published in the Medicine Journal has shed light on the safety and efficacy of...
Low birthweight and obesity during adolescence linked to substantial risk of diabetes: Study Written By Dr. Shravani Dali2 March 2024 3:00 AM ISTLow birthweight and overweight during adolescence tied to a substantial risk of diabetes suggests a new study published in the Diabetologia.This study...
Once-weekly survodutide safely tied to substantial weight loss in obese individuals: Study Written By Medha Baranwal29 Feb 2024 10:00 PM ISTGermany: In adults with a BMI of 27 kg/m2 or greater without diabetes, once-weekly survodutide produced significant reductions in body weight versus...
Eli Lilly expects to launch diabetes drug Mounjaro in India next year: CEO Written By Ruchika Sharma29 Feb 2024 12:30 PM ISTMounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both conditions.
Bariatric surgery provides superior long-term treatment for type 2 diabetes in patients with obesity: JAMA Written By Dr. Kamal Kant Kohli28 Feb 2024 7:00 PM ISTResearch by Cleveland Clinic and three other U.S. medical centers has found that bariatric surgery provides better long-term control of blood glucose...
Diabetes independent risk factor for low back pain, disc degeneration: Study Written By Jacinthlyn Sylvia28 Feb 2024 2:00 AM ISTA recent study published in the PNAS Nexus explored how diabetes affects the biomechanics of intervertebral discs that can offer crucial insights...
Triple combo of alpha-lipoic acid, epalrestat, and mecobalamin better for treating diabetic peripheral neuropathy than monotherapy : study Written By Dr. Shravani Dali27 Feb 2024 2:00 AM ISTA triple combo of alpha-lipoic acid, epalrestat, and mecobalamin is better for treating diabetic peripheral neuropathy than monotherapy finds a new ...
Tirzepatide, novel agent for treating type 2 diabetes has different efficacy in Asians and non-Asians: Study Written By Medha Baranwal27 Feb 2024 1:00 AM ISTChina: A recent meta-analysis published in Diabetes Therapy has shed light on the comparative safety and efficacy of tirzepatide in Asians and...
GLP-1 receptor agonists can dial down inflammation in the brain, raising hopes for treating neurodegenerative diseases Written By Medha Baranwal26 Feb 2024 11:45 PM ISTUSA: Evidence suggests that glucagon-like peptide 1 (GLP-1) receptor agonists that reduce obesity can reduce inflammation in the kidneys, liver and...
Bariatric surgery may induce weight loss and improve Thyroid Functions: Study Written By Dr.Niharika Harsha B26 Feb 2024 8:30 PM ISTIn a groundbreaking study, researchers have uncovered the intricate relationship between bariatric surgery, thyroid function, and postoperative...
High-sensitivity CRP and monocyte to HDL ratio associated with Increased Type 2 Diabetes Risk: BMC study Written By Jacinthlyn Sylvia25 Feb 2024 11:00 PM ISTA recent study published in the Journal of Translational Medicine explored the intricate relationship between monocytic inflammation, C-reactive...
Disruption of multiple complement proteins linked to development of islet autoimmunity and type 1 diabetes: Study Written By Jacinthlyn Sylvia23 Feb 2024 8:30 PM ISTA recent study published in the journal of iScience explored the important role of the complement system in the early stages of Type 1 Diabetes (T1D)...
